Abstract
Purpose
To determine factors associated with vision loss 1 year after Ahmed glaucoma valve (AGV) surgery in Black or Hispanic patients, who bear disproportionate glaucoma burdens yet have been underrepresented in pivotal trials.
Methods
This retrospective study included Black or Hispanic patients who received AGVs standalone or combined with phacoemulsification and/or cyclodestructive lasers. Univariate and multivariate generalized estimating equations evaluated the effects of baseline, surgical, and postoperative factors on vision loss of two Snellen lines or more at the 1-year follow-up visit. The primary term was the hypertensive phase (HP), which signified an intraocular pressure (IOP) reading > 21 mmHg within the first 3 postoperative months after reduction below 22 in the first week, without other tube malfunction.
Results
Of 241 eyes from 186 patients, vision loss of ≥ 2 lines at the 1-year follow-up visit occurred in 21.6% (N = 52). Vision loss of ≥ 2 lines occurred in 52.5% of eyes at week 1, 36.9% of eyes at month 1, and 27.0% of eyes at month 3. Between 6 months and 1 year, vision loss frequencies stabilized. In the multivariate model, HP (OR = 4.71 (2.14, 10.38)), total quadrants with split fixation (1.47 (1.20, 1.81)), follow-up non-glaucomatous eye pathology (2.89 (1.44, 5.80)), and concurrent cataract surgery (0.42 (0.22, 0.82)) each met significance (p < 0.05).
Conclusion
Post-AGV vision loss in the early follow-up period among Black or Hispanic patients was often transient. Hypertensive phase and split fixation each increased the odds of vision loss at 1 year, while concurrent cataract surgery decreased the odds.
Similar content being viewed by others
References
Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, Li T, Mansberger SL (2021) Primary open-angle glaucoma preferred practice pattern®. Ophthalmology 128:P71-p150. https://doi.org/10.1016/j.ophtha.2020.10.022
Riva I, Roberti G, Oddone F, Konstas AG, Quaranta L (2017) Ahmed glaucoma valve implant: surgical technique and complications. Clin Ophthalmol 11:357–367. https://doi.org/10.2147/opth.S104220
Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM (2011) Treatment outcomes in the Ahmed Baerveldt comparison study after 1 year of follow-up. Ophthalmology 118:443–452. https://doi.org/10.1016/j.ophtha.2010.07.016
Christakis PG, Kalenak JW, Zurakowski D, Tsai JC, Kammer JA, Harasymowycz PJ, Ahmed IIK (2011) The Ahmed versus Baerveldt study: one-year treatment outcomes. Ophthalmology 118:2180–2189. https://doi.org/10.1016/j.ophtha.2011.05.004
Lee CK, Ma KT, Hong YJ, Kim CY (2017) Long-term clinical outcomes of Ahmed valve implantation in patients with refractory glaucoma. PLoS One 12:e0187533–e0187533. https://doi.org/10.1371/journal.pone.0187533
Kim EL, Tran J, Töteberg-Harms M, Chahal J, Rhee D, Chopra V, Francis B (2017) Vision loss and recovery after Baerveldt aqueous tube shunt implantation. J Ophthalmol 2017:4140305. https://doi.org/10.1155/2017/4140305
Francis BA, Hong B, Winarko J, Kawji S, Dustin L, Chopra V (2011) Vision loss and recovery after trabeculectomy: risk and associated risk factors. Arch Ophthalmol 129:1011–1017. https://doi.org/10.1001/archophthalmol.2011.182
Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663. https://doi.org/10.1016/j.ophtha.2018.02.003
Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL (2007) Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol 143:9–22. https://doi.org/10.1016/j.ajo.2006.07.020
Christakis PG, Zhang D, Budenz DL, Barton K, Tsai JC, Ahmed IIK (2017) Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol 176:118–126. https://doi.org/10.1016/j.ajo.2017.01.003
Law SK, Nguyen AM, Coleman AL, Caprioli J (2007) Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol 125:1044–1050. https://doi.org/10.1001/archopht.125.8.1044
Liu Y, Huang L, Zhao Q, Liu Q, Stamper RL, Han Y (2020) Short-term postoperative visual acuity decrease and recovery after Ahmed tube shunt procedure for glaucoma. Ophthalmol Glaucoma 3:384–392. https://doi.org/10.1016/j.ogla.2020.04.006
Halawa OA, Kolli A, Oh G, Mitchell WG, Glynn RJ, Kim DH, Friedman DS, Zebardast N (2021) Racial and socioeconomic differences in eye care utilization among medicare beneficiaries with glaucoma. Ophthalmology. https://doi.org/10.1016/j.ophtha.2021.09.022
Nathan N, Joos KM (2016) Glaucoma disparities in the Hispanic population. Semin Ophthalmol 31:394–399. https://doi.org/10.3109/08820538.2016.1154165
Kim E, Varma R (2010) Glaucoma in Latinos/Hispanics. Curr Opin Ophthalmol 21:100–105. https://doi.org/10.1097/ICU.0b013e3283360b1e
Elbaklish KH, Gomaa WA (2020) A one-year follow-up of two Ahmed glaucoma valve models (S2 and FP7) for refractory glaucoma: a prospective randomized trial. Clin Ophthalmol (Auckland, NZ) 14:693–705. https://doi.org/10.2147/OPTH.S224653
Pham CN, Radcliffe NM, Vu DM (2018) Surgical outcomes associated with a sutureless drainage valve implantation procedure in patients with refractory glaucoma. Clin Ophthalmol (Auckland, NZ) 12:2607–2615. https://doi.org/10.2147/OPTH.S186369
Budenz DL, Barton K, Gedde SJ, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM (2015) Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology 122:308–316. https://doi.org/10.1016/j.ophtha.2014.08.043
Budenz DL, Feuer WJ, Barton K, Schiffman J, Costa VP, Godfrey DG, Buys YM (2016) Postoperative complications in the Ahmed Baerveldt comparison study during five years of follow-up. Am J Ophthalmol 163:75-82.e73. https://doi.org/10.1016/j.ajo.2015.11.023
Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, Kammer JA, Harasymowycz PJ, Mura JJ, Cantor LB, Ahmed II (2016) The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology 123:2093–2102. https://doi.org/10.1016/j.ophtha.2016.06.035
Moussa G, Bassilious K, Mathews N (2020) A novel excel sheet conversion tool from Snellen fraction to LogMAR including ‘counting fingers’, ‘hand movement’, ‘light perception’ and ‘no light perception’ and focused review of literature of low visual acuity reference values. Acta Ophthalmol. https://doi.org/10.1111/aos.14659
Won HJ, Sung KR (2016) Hypertensive phase following silicone plate Ahmed glaucoma valve implantation. J Glaucoma 25:e313-317. https://doi.org/10.1097/ijg.0000000000000249
Ying GS, Maguire MG, Glynn R, Rosner B (2018) Tutorial on biostatistics: statistical analysis for correlated binary eye data. Ophthalmic Epidemiol 25:1–12. https://doi.org/10.1080/09286586.2017.1320413
Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138:923–936. https://doi.org/10.1093/oxfordjournals.aje.a116813
Chen H, Cohen P, Chen S (2010) How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun Stat Simul Comput 39:860–864. https://doi.org/10.1080/03610911003650383
Pitukcheewanont O, Tantisevi V, Chansangpetch S, Rojanapongpun P (2018) Factors related to hypertensive phase after glaucoma drainage device implantation. Clin Ophthalmol 12:1479–1486. https://doi.org/10.2147/opth.S166244
Fargione RA, Tansuebchueasai N, Lee R, Tania Tai TY (2019) Etiology and management of the hypertensive phase in glaucoma drainage-device surgery. Surv Ophthalmol 64:217–224. https://doi.org/10.1016/j.survophthal.2018.10.008
Chansangpetch S, Surukrattanaskul S, Tapaneeyangkul P, Tantisevi V (2018) Hypertensive phase and its association with surgical outcomes in Baerveldt implantation. Int Ophthalmol 38:1717–1725. https://doi.org/10.1007/s10792-017-0654-8
Cui QN, Hsia YC, Lin SC, Stamper RL, Rose-Nussbaumer J, Mehta N, Porco TC, Naseri A, Han Y (2017) Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation. Clin Exp Ophthalmol 45:128–134. https://doi.org/10.1111/ceo.12811
Perez CI, Verdaguer S, Khaliliyeh D, Maul EA, Ou Y, Han Y (2021) Subconjunctival injections of mitomycin C are associated with a lower incidence of hypertensive phase in eyes with Ahmed glaucoma valve. Ophthalmol Glaucoma 4:322–329. https://doi.org/10.1016/j.ogla.2020.10.004
Mohammadzadeh V, Galian K, Martinyan J, Nouri-Mahdavi K (2019) Vision loss after glaucoma surgery: progressive macular thinning as a sign of snuff-out phenomenon. J Glaucoma 28:e99–e102. https://doi.org/10.1097/ijg.0000000000001202
Schrieber C, Liu Y (2015) Choroidal effusions after glaucoma surgery. Curr Opin Ophthalmol 26:134–142. https://doi.org/10.1097/icu.0000000000000131
Young CEC, Seibold LK, Kahook MY (2020) Cataract surgery and intraocular pressure in glaucoma. Curr Opin Ophthalmol 31:15–22. https://doi.org/10.1097/icu.0000000000000623
Barton K, Gedde SJ, Budenz DL, Feuer WJ, Schiffman J (2011) The Ahmed Baerveldt comparison study methodology, baseline patient characteristics, and intraoperative complications. Ophthalmology 118:435–442. https://doi.org/10.1016/j.ophtha.2010.07.015
Christakis PG, Tsai JC, Zurakowski D, Kalenak JW, Cantor LB, Ahmed II (2011) The Ahmed versus Baerveldt study: design, baseline patient characteristics, and intraoperative complications. Ophthalmology 118:2172–2179. https://doi.org/10.1016/j.ophtha.2011.05.003
Goulet RJ 3rd, Phan AD, Cantor LB, WuDunn D (2008) Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology 115:1141–1147. https://doi.org/10.1016/j.ophtha.2007.10.034
Ishida K, Netland PA (2006) Ahmed glaucoma valve implantation in African American and white patients. Arch Ophthalmol 124:800–806. https://doi.org/10.1001/archopht.124.6.800
Vespa J, Armstrong DM, Medina L (2018) Demographic turning points for the United States: population projections for 2020 to 2060. Current Population Reports P25 1144
Kim JY, Lee JS, Lee T, Seo D, Choi W, Bae HW, Kim CY (2021) Corneal endothelial cell changes and surgical results after Ahmed glaucoma valve implantation: ciliary sulcus versus anterior chamber tube placement. Sci Rep 11:12986. https://doi.org/10.1038/s41598-021-92420-8
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
This research study was conducted retrospectively from data obtained for clinical purposes. An IRB official waiver of ethical approval was granted from the Sterling IRB. All research was performed in accordance with the Health Insurance Portability and Accountability Act of 1996 and adhered to tenets of the Declaration of Helsinki.
Consent to participate
The need for informed consent was waived owing to the retrospective study design.
Competing interests
This study was supported in part by an Alpha Omega Alpha Carolyn L Kuckein Student Research Fellowship. Author NMR reports the following: CATS LLC—Consultant (C). Allergan—C, Speaker (S). Alcon—C, S. Novartis—C, S. Ellex—C. Eyenovia—C. Lumenis—C. ELT Sight—C, Equity (E). Equinox—C, Investor (I). Iridex—C. Aerie—C, S. Bausch & Lomb/Valeant—C, S. BVI—C, S. Eyepoint—C. Ivantis—C, S. Glaukos—C, S. Alimera—C, S. Kala Lumenis Inc—C, S, New World Medical—C, S. SpyGlass—C. Sight Sciences—C, S. Santen, Inc—C. Thea—C. Reichert—C. Shire—C. Carl Zeiss Meditec—C. Ocular Science—C. Ocular Therapeutix—C. Omeros—C. Quantel Medical—C. ViaLase—C. The authors have no other competing interests to declare that are relevant to the content of this article.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Preliminary data was presented at the Association for Research in Vision and Ophthalmology’s 2021 annual meeting under the title, “Combination of split fixation and hypertensive phase is associated with vision loss in Latino and Black patients following Ahmed Glaucoma Valve surgery.”.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tan, N.E., Chen, S.X. & Radcliffe, N.M. Factors associated with vision loss in Black or Hispanic patients 1 year after standalone or combined Ahmed glaucoma valve surgery. Graefes Arch Clin Exp Ophthalmol 260, 3565–3575 (2022). https://doi.org/10.1007/s00417-022-05804-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-022-05804-5